+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
Bullous Pemphigoid - Pipeline Insight, 2025 - Product Thumbnail Image

Bullous Pemphigoid - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Vitiligo - Pipeline Insight, 2025 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
From
Cholestatic Pruritus- Pipeline Insight, 2025 - Product Thumbnail Image

Cholestatic Pruritus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Idiopathic Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Idiopathic Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Nail Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Nail Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Common Warts - Pipeline Insight, 2025 - Product Thumbnail Image

Common Warts - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Prurigo Nodularis - Pipeline Insight, 2025 - Product Thumbnail Image

Prurigo Nodularis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Psoriasis Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Tinea Pedis - Pipeline Insight, 2025 - Product Thumbnail Image

Tinea Pedis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Papulopustular Rosacea- Pipeline Insight, 2025 - Product Thumbnail Image

Papulopustular Rosacea- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pressure Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Pressure Ulcers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Impetigo - Pipeline Insight, 2025 - Product Thumbnail Image

Impetigo - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more